Invesaro

Stocks Comparison

agilon health vs Davita: revenue, profit, margins and growth compared

agilon health brought in $5.9B of revenue in fiscal 2025, Davita $13.6B in fiscal 2025. Revenue changed by -2.1% at agilon health and +6.5% at Davita on the year before, so Davita grew faster. agilon health kept -6.6% of its revenue as net profit, Davita 5.5%. Free cash flow was -$119M at agilon health and $1.3B at Davita.

Side by side, latest fiscal year

AGLDVA
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$5.9B$13.6B
Revenue growth-2.1%+6.5%
Net income-$391.3M$746.8M
Net margin-6.6%5.5%
Free cash flow-$119M$1.3B
Free cash flow margin-2.0%9.6%
Earnings per share (diluted)n/a$9.84
Cash$173.7M$676.4M
Debt$35M$10.3B
Price to earningsn/a18.1
Market value$1.4B$11.4B
Dividend yieldn/an/a
Rank by revenue in sector#57 of 523 · Health care#36 of 523 · Health care

Over the years

Revenue
AGL FY2019: $794.4MAGL FY2021: $1.2BAGL FY2021: $1.5BAGL FY2022: $2.4BAGL FY2023: $4.3BAGL FY2024: $6.1BAGL FY2025: $5.9BDVA FY2018: $11.4BDVA FY2019: $11.4BDVA FY2020: $11.6BDVA FY2021: $11.6BDVA FY2022: $11.6BDVA FY2023: $12.1BDVA FY2024: $12.8BDVA FY2025: $13.6BFY18FY19FY20FY21FY22FY23FY24FY25
AGL $5.9BDVA $13.6B
Net income
AGL FY2019: -$282.6MAGL FY2021: -$60.1MAGL FY2021: -$406.5MAGL FY2022: -$106.6MAGL FY2023: -$262.6MAGL FY2024: -$260.2MAGL FY2025: -$391.3MDVA FY2018: $159.4MDVA FY2019: $811MDVA FY2020: $773.6MDVA FY2021: $978.5MDVA FY2022: $560.4MDVA FY2023: $691.5MDVA FY2024: $936.3MDVA FY2025: $746.8MFY18FY19FY20FY21FY22FY23FY24FY25
AGL -$391.3MDVA $746.8M
Net margin
AGL FY2019: -35.6%AGL FY2021: -4.9%AGL FY2021: -26.7%AGL FY2022: -4.5%AGL FY2023: -6.1%AGL FY2024: -4.3%AGL FY2025: -6.6%DVA FY2018: 1.4%DVA FY2019: 7.1%DVA FY2020: 6.7%DVA FY2021: 8.4%DVA FY2022: 4.8%DVA FY2023: 5.7%DVA FY2024: 7.3%DVA FY2025: 5.5%FY18FY19FY20FY21FY22FY23FY24FY25
AGL -6.6%DVA 5.5%
Revenue growth
AGL FY2021: +53.4%AGL FY2021: +24.9%AGL FY2022: +57.0%AGL FY2023: +80.7%AGL FY2024: +40.4%AGL FY2025: -2.1%DVA FY2019: -0.1%DVA FY2020: +1.4%DVA FY2021: +0.6%DVA FY2022: -0.1%DVA FY2023: +4.6%DVA FY2024: +5.6%DVA FY2025: +6.5%FY19FY20FY21FY22FY23FY24FY25
AGL -2.1%DVA +6.5%
Free cash flow
AGL FY2019: -$106.8MAGL FY2021: -$55MAGL FY2021: -$154.7MAGL FY2022: -$146.2MAGL FY2023: -$172MAGL FY2024: -$71MAGL FY2025: -$119MDVA FY2018: $784.5MDVA FY2019: $1.3BDVA FY2020: $1.3BDVA FY2021: $1.3BDVA FY2022: $961.1MDVA FY2023: $1.5BDVA FY2024: $1.5BDVA FY2025: $1.3BFY18FY19FY20FY21FY22FY23FY24FY25
AGL -$119MDVA $1.3B

Fiscal years as each company reports them; the two may end in different months.

Questions about agilon health and Davita

Which is bigger by revenue, agilon health or Davita?

Davita is bigger by revenue: $13.6B in fiscal 2025, against $5.9B for agilon health in fiscal 2025.

Which keeps more of its revenue as profit, agilon health or Davita?

agilon health had a net margin of -6.6% in fiscal 2025; Davita had 5.5% in fiscal 2025.

Which grew revenue faster, agilon health or Davita?

In their latest fiscal years revenue changed by -2.1% at agilon health and +6.5% at Davita.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies